Sanofi
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

Abstract:

The present invention refers to a pharmaceutical composition comprising (a) lixisenatide or/and a pharmaceutically acceptable salt thereof, and (b) insulin glargine or/and a pharmaceutically acceptable salt thereof, wherein the compound (b) and compound (a) are present in a fixed ratio.